<DOC>
	<DOCNO>NCT01786590</DOCNO>
	<brief_summary>It report 90,000 patient die lung cancer 20 % old 80 year North America . Therefore less invasive effective treatment require patient lung cancer advance age , diminish pulmonary function , chronic disease . Stereotactic body radiation therapy ( SBRT ) effective well-tolerated treatment early stage lung cancer medically inoperable patient . On hand , accurate mediastinal hilar lymph node stag one important factor determine outcome indication SBRT . Endobronchial ultrasound-guided transbronchial needle aspiration ( EBUS-TBNA ) novel , minimally invasive modality enable assessment mediastinal hilar lymph node high sensitivity . Accurate lymph node stag EBUS-TBNA allow opportunity high-risk patient lung cancer undergo minimally invasive treatment .</brief_summary>
	<brief_title>Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Lymph Node Staging Patients With Non-small Cell Lung Cancer Pursuing Stereotactic Body Radiotherapy ( SBRT )</brief_title>
	<detailed_description>Patients radiologically early stage lung cancer candidate SBRT enrol study . Prior enrollment , patient require evaluated experienced thoracic surgeon , radiation oncologist medical oncologist determine operability . Patients udergo compute tomography ( CT ) positron emission tomography ( PET ) prior EBUS- TBNA . EBUS-TBNA perform Interventional Thoracic Surgery Suite ( ITSS ) locate Toronto General Hospital Thoracic Surgeon . The procedure perform local anesthesia conscious sedation . Mediastinal well hilar lymph node assess EBUS-TBNA . The result pathological diagnosis use EBUS-TBNA compare result radiological staging ( CT PET-CT ) . Patients negative mediastinal lymph node metastasis EBUS-TBNA undergo SBRT . In addition , treatment outcome evaluate base clinical chart review .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Age 18 year old 2 . Patients confirm lung cancer require EBUSTBNA part stag investigation mediastinum hilum prior SBRT 3 . Performance status score ( WHO/ECOG ) 02 . 4 . Cytological histological proof nonsmall cell cancer 5 . Stage T12 disease , evidence distant metastasis 6 . Patients screen computed tomography ( CT ) positron emission tomography ( PET ) 7 . Medically inoperable surgical resection 8 . Patients refuse surgery 1 . Patients deem clinical ground medically fit bronchoscopy 2 . Active systemic , pulmonary , pericardial infection 3 . Patients pregnant lactate 4 . Patients plan receive conventional radiotherapy , chemotherapy , biological therapy , vaccine therapy , surgery treatment ( except disease progression ) . 5 . Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>